Research summaries for everyoneNot medical advice
KPV research reference vial, Elevated Pharma

Research reference · Skin & Collagen

KPV

KPV is the tripeptide lysine-proline-valine, the C-terminal end of alpha-MSH. It is studied in cell and mouse models of inflammation, especially colitis.

Published by Elevated Pharma ·

Skin & CollagenPreclinical literature

Identity

What is KPV?

A three-residue peptide, Lys-Pro-Val, taken up into cells by the PepT1 transporter.

Research context

What has KPV been studied for?

Published work is preclinical: colitis models in mice, skin and macrophage cell studies, and new oral delivery systems. No completed human trial was found.

Evidence boundary

What does the research not show?

Cell and animal findings are not human outcome evidence.

U.S. status · November 7, 2026

Is KPV FDA-approved?

FDA removed it from its Category 2 compounding list in April 2026, and FDA’s compounding advisory committee recommended it for the 503A bulks list on July 23, 2026 (vote 8–6, one abstention). On October 28, 2026, HHS issued an interim policy saying it will not take enforcement action against licensed pharmacies and physicians that compound it under listed conditions, such as FDA-registered sourcing, a certificate of analysis and safety reporting. It is not FDA-approved, and the policy does not cover research-use-only material.

Research updates

What’s new

Dated developments for KPV, newest first. See all research updates.

  1. HHS interim compounding policy

    HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.

    Read the source
  2. FDA advisory committee votes

    FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).

    Read the source

Key studies

The main KPV research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all 49 PubMed records for KPV · Counts and selections checked November 7, 2026.

Reference identifiers

KPV identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
KPV
Also indexed as
Lys-Pro-Val / Lysine-proline-valine
Sequence
Lys-Pro-Val
Molecular formula
C16H30N4O4
Molecular mass
342.43 g/mol
PubChem CID
125672

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.